MATSON, INC. ANNOUNCES THIRD QUARTER 2023 RESULTS
3Q23 EPS of $3.403Q23 Net Income and EBITDA of $119.9 million and $175.1 million, respectivelyYear-over-year decrease in 3Q23 consolidated operati...
Stay updated with breaking news from Matson Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
3Q23 EPS of $3.403Q23 Net Income and EBITDA of $119.9 million and $175.1 million, respectivelyYear-over-year decrease in 3Q23 consolidated operati...
Matson (NYSE:MATX – Free Report) had its target price hoisted by Stifel Nicolaus from $90.00 to $102.00 in a research note published on Tuesday morning, Benzinga reports. The firm currently has a hold rating on the shipping company’s stock. Other equities research analysts have also issued reports about the stock. StockNews.com lowered shares of Matson […]
Jackson Creek Investment Advisors LLC acquired a new stake in Matson, Inc. (NYSE:MATX – Free Report) during the second quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 12,872 shares of the shipping company’s stock, valued at approximately $1,001,000. A number of other institutional investors and hedge funds have also […]
U.S. stocks traded higher Tuesday, with the Nasdaq Composite gaining over 100 points. Here are some big stocks recording gains in the trading session. ImmunityBio, Inc. (NASDAQ: IBRX) shares rose 31.4% to $1.88.
U.S. stocks traded higher Tuesday, with the Nasdaq Composite gaining over 100 points. Here are some big stocks recording gains in the trading sess...